-
Belatacept Every Two Month Maintenance Dosing in Kidney Transplantation: A Randomized, Non-Inferiority Trial
-
Belatacept in Kidney Transplant Recipients with Previous Non-Renal Solid Organ Transplants
-
Belatacept Monthly Therapy: Transplant Recipients’ Experience
-
Belatacept Provides Superior Inhibition of Donor Specific Antibody Formation in Kidney Transplant Recipients with Acute Rejection
-
Belatacept Removal by Plasmapheresis: Kinetics, Dose Adjustments and Clinical Recommendations
-
Belatacept Suppresses the B-Cell Alloresponse in the Lower Range of Therapeutic Trough Concentrations
-
Belatacept versus Tacrolimus Combined with Antithymocyte Globulin in Kidney Transplantation
-
Belatacept-Based Regimens: Induction and Recipient Gender Influence Outcomes
-
Belatacept-Based, Calcineurin Inhibitor and Corticosteroid Free Immunosuppression: Differential Outcomes Based on Recipient Age
-
Benefits of Normothermia Regional Perfusion (NRP), Hypothermic Machine Perfusion (HMP) and Short Cold Ischemia Time (CIT) for Kidney Transplants with Controlled Donation after Circulatory Death (cDCD)
- « Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- …
- 223
- Next Page »